Search
NeuroPace Increases 2025 Revenue Projections
2025-08-14 /
Read about 0 minute
Author：小编
The medical device manufacturer NeuroPace has revised its revenue projections for 2025 upwards, estimating a range between $94 million and $98 million. This optimistic outlook is primarily fueled by robust sales growth of its Responsive Neurostimulation (RNS) system. Furthermore, the company has successfully completed a debt refinancing, significantly bolstering its financial agility and providing a solid foundation for the execution of its strategic plan.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
